338 results
Page 10 of 17
424B5
z08h0uj1a76ra9i1zq
16 Jun 10
Prospectus supplement for primary offering
12:00am
424B3
wgl6h
15 Jun 10
Prospectus supplement
12:00am
8-K
vpk939v 2e
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-10.1
b8qw0n7c6 ym37pq5r
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-4.1
70bhpv4y20 3856o4
14 Jun 10
Discovery Labs Secures $35 Million Committed Equity Financing Facility
12:00am
8-K
EX-99.1
ubtxrk w62
21 May 10
Discovery Labs Achieves Key Milestone Towards Potential Surfaxin® Approval
12:00am
424B5
w40ehj2asyn00np6pi
28 Apr 10
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
vur0t kj1
28 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
jy57xlyzw
28 Apr 10
Discovery Labs Provides Updates on Surfaxin®, Other Key Programs and First Quarter 2010 Financial Results
12:00am
8-K
nplhbx z4
28 Apr 10
Entry into a Material Definitive Agreement
12:00am
S-8
EX-5.1
wjers840 nrur
31 Mar 10
Registration of securities for employees
12:00am
424B5
88x38wh egtsz
19 Feb 10
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
sqp5t8k1o 85hik
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
8-K
EX-4.1
od4cb67u2213i1u09f
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
8-K
kwq037za7wf3cr
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
8-K
EX-1.1
5p7a9x7wfozxvdxbukg2
18 Feb 10
Discovery Labs Prices $16.5 Million Public Offering of
12:00am
424B5
u3n40c0s
17 Feb 10
Prospectus supplement for primary offering
12:00am